Financials
- Market Capitalization 1.65 M
- Employee 2
- Founded 2004
- CEO N/A
- Website www.bonebiologics.com
- Headquarter Delaware, United States
- FIGI BBG007GF2K51
- Industry Medical Devices
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 5066 | AEMD Aethlon Medical, Inc. - Common Stock | 2.47 USD | +13.82% | -9.52% | +357.41% | +22.91% | 1.76 M USD | ||
| 5071 | PFSA Profusa, Inc. - Common Stock | 2.89 USD | -31.84% | -47.07% | +194.90% | +613.40% | 1.75 M USD | ||
| 6609 | BIO-B Bio-Rad Laboratories, Inc. Class B Common Stock | 365.08 USD | 0.00% | 0.00% | 0.00% | +28.62% | 10.51 B USD | ||
| 6625 | BRKRP Bruker Corporation - 6.375% Mandatory Convertible Preferred Stock, Series A | 420.32 USD | -3.90% | -4.34% | -8.42% | +62.91% | 8.85 B USD |
Frequently asked questions about Bone Biologics Corp Common Stock
What is the Bone Biologics Corp Common Stock stock price today?
The current price of Bone Biologics Corp Common Stock (BBLG) is 0.60. Over the past 24 hours, the stock has changed by -3.23%. Follow the BBLG chart for real-time price dynamics.
What is the stock ticker of Bone Biologics Corp Common Stock?
Bone Biologics Corp Common Stock trades under the ticker BBLG. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Bone Biologics Corp Common Stock stock going up?
BBLG has changed by -4.76% over the last week, -36.17% over the last month, and -52.00% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Bone Biologics Corp Common Stock?
Bone Biologics Corp Common Stock currently has a market capitalization of 1.65 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Bone Biologics Corp Common Stock earnings last quarter?
Last quarter, Bone Biologics Corp Common Stock reported earnings of -0.43 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Bone Biologics Corp Common Stock revenue for the last quarter?
Bone Biologics Corp Common Stock reported quarterly revenue of 0. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Bone Biologics Corp Common Stock net income for the last quarter?
Bone Biologics Corp Common Stock reported net income of -773.7 K for the last quarter. The previous quarter showed -765.99 K, which means net income changed by -1.01%.
How many employees does Bone Biologics Corp Common Stock have?
As of the latest available data, Bone Biologics Corp Common Stock has 2 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy Bone Biologics Corp Common Stock stock?
You can buy Bone Biologics Corp Common Stock (BBLG) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Bone Biologics Corp Common Stock stock?
Investing in Bone Biologics Corp Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the BBLG chart and related analysis on metatrader.com as part of your research.